![Cancers | Free Full-Text | Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI Cancers | Free Full-Text | Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI](https://pub.mdpi-res.com/cancers/cancers-14-02702/article_deploy/html/images/cancers-14-02702-g001-550.jpg?1653911161)
Cancers | Free Full-Text | Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
![Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/ab17d97b-9319-4a00-9a54-1261444c76dc/gr1_lrg.jpg)
Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus
![Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/693684/693684_Thumb_400.jpg)
Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study
![MP56-09 A RISK CALCULATOR INCORPORATING MRI-GUIDED BIOPSY DATA TO PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER | Journal of Urology MP56-09 A RISK CALCULATOR INCORPORATING MRI-GUIDED BIOPSY DATA TO PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER | Journal of Urology](https://www.auajournals.org/cms/asset/c14cc58a-dba4-426f-9e72-f09b0e565ced/ju.0000000000000925.09t1.gif)
MP56-09 A RISK CALCULATOR INCORPORATING MRI-GUIDED BIOPSY DATA TO PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER | Journal of Urology
![Can Western Based Online Prostate Cancer Risk Calculators Be Used to Predict Prostate Cancer after Prostate Biopsy for the Korean Population? Can Western Based Online Prostate Cancer Risk Calculators Be Used to Predict Prostate Cancer after Prostate Biopsy for the Korean Population?](https://www.eymj.org/ArticleImage/0069YMJ/ymj-54-665-i001-l.jpg)
Can Western Based Online Prostate Cancer Risk Calculators Be Used to Predict Prostate Cancer after Prostate Biopsy for the Korean Population?
![The use of prostate specific antigen density to predict clinically significant prostate cancer | Scientific Reports The use of prostate specific antigen density to predict clinically significant prostate cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-76786-9/MediaObjects/41598_2020_76786_Fig1_HTML.png)
The use of prostate specific antigen density to predict clinically significant prostate cancer | Scientific Reports
![When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2015/02/tnpcil2.png)
When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK
![Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-017-0024-7/MediaObjects/41391_2017_24_Fig1_HTML.jpg)
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases
![SciELO - Brasil - Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and SciELO - Brasil - Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and](https://minio.scielo.br/documentstore/1677-6119/5GWVS9m8y55TZvZ89YVmVbz/e3f287786901ff1f9230b1df00909c7c5795c03c.gif)
SciELO - Brasil - Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and
![Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy](https://www.mdpi.com/cancers/cancers-14-02374/article_deploy/html/images/cancers-14-02374-g002b.png)